This inventor holds 5 USPTO granted patents. Top assignees: St. Jude Children's Research Hospital, Curevac Se. Active years: 1998-2025.
Location History:
- Memphis, TN (US) (1998 - 2004)
- Somerville, MA (US) (2017 - 2019)
Company Filing History:
Years Active: 1998-2025
Title: Karen Slobod: Innovator in mRNA Vaccine Technology
Introduction
Karen Slobod is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of vaccine technology, particularly in the development of mRNA vaccines. With a total of 5 patents to her name, her work has the potential to impact public health significantly.
Latest Patents
One of her latest patents focuses on influenza mRNA vaccines. This invention relates to mRNA sequences that can be used as mRNA-based vaccines against infections with influenza viruses. The patent also describes a composition comprising these mRNA sequences and their use in preparing pharmaceutical compositions, especially vaccines for the prophylaxis or treatment of influenza virus infections. Additionally, it outlines a method for treating or preventing infections with influenza viruses using these mRNA sequences.
Another notable patent is for a modified Sendai virus vaccine and imaging vector. This invention involves a Sendai virus or recombinant Sendai virus vector. It provides methods, vectors, formulations, compositions, and kits for a modified Enders strain Sendai viral vector. The immunogenic vector can be utilized in various in vitro or in vivo systems, and some embodiments include vectors for imaging virus growth, location, and transmission.
Career Highlights
Throughout her career, Karen has worked with esteemed organizations such as St. Jude Children's Research Hospital and CureVac SE. Her experience in these institutions has allowed her to advance her research and contribute to groundbreaking innovations in vaccine technology.
Collaborations
Karen has collaborated with notable colleagues, including Julia Lea Hurwitz and Toru Takimoto. These partnerships have further enriched her research and development efforts in the field of mRNA vaccines.
Conclusion
Karen Slobod is a trailblazer in the realm of mRNA vaccine technology, with a focus on influenza and Sendai virus innovations. Her contributions are paving the way for advancements in vaccine development and public health.